These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 9624146

  • 1. Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase.
    Fisher DA, Smith JF, Pillar JS, St Denis SH, Cheng JB.
    J Biol Chem; 1998 Jun 19; 273(25):15559-64. PubMed ID: 9624146
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Identification and characterization of a novel family of cyclic nucleotide phosphodiesterases.
    Soderling SH, Bayuga SJ, Beavo JA.
    J Biol Chem; 1998 Jun 19; 273(25):15553-8. PubMed ID: 9624145
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Identification and characterization of DdPDE3, a cGMP-selective phosphodiesterase from Dictyostelium.
    Kuwayama H, Snippe H, Derks M, Roelofs J, Van Haastert PJ.
    Biochem J; 2001 Feb 01; 353(Pt 3):635-44. PubMed ID: 11171061
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hydropathic analysis and mutagenesis of the catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase (PDE5). cGMP versus cAMP substrate selectivity.
    Turko IV, Francis SH, Corbin JD.
    Biochemistry; 1998 Mar 24; 37(12):4200-5. PubMed ID: 9521742
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (Type 5) by sildenafil and related compounds.
    Turko IV, Ballard SA, Francis SH, Corbin JD.
    Mol Pharmacol; 1999 Jul 24; 56(1):124-30. PubMed ID: 10385692
    [Abstract] [Full Text] [Related]

  • 17. Probing domain functions of chimeric PDE6alpha'/PDE5 cGMP-phosphodiesterase.
    Granovsky AE, Natochin M, McEntaffer RL, Haik TL, Francis SH, Corbin JD, Artemyev NO.
    J Biol Chem; 1998 Sep 18; 273(38):24485-90. PubMed ID: 9733741
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Crystal structure of phosphodiesterase 9 shows orientation variation of inhibitor 3-isobutyl-1-methylxanthine binding.
    Huai Q, Wang H, Zhang W, Colman RW, Robinson H, Ke H.
    Proc Natl Acad Sci U S A; 2004 Jun 29; 101(26):9624-9. PubMed ID: 15210993
    [Abstract] [Full Text] [Related]

  • 20. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells.
    Lugnier C, Schini VB.
    Biochem Pharmacol; 1990 Jan 01; 39(1):75-84. PubMed ID: 2153383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.